Vanguard Group’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.3M | Buy |
|
|||||
|
2025
Q1 | $18.1M | Buy |
|
|||||
|
2024
Q4 | $22.4M | Buy |
|
|||||
|
2024
Q3 | $27.3M | Buy |
|
|||||
|
2024
Q2 | $13.5M | Buy |
|
|||||
|
2024
Q1 | $20.9M | Buy |
|
|||||
|
2023
Q4 | $20M | Buy |
|
|||||
|
2023
Q3 | $3.09M | Buy |
|
|||||
|
2023
Q2 | $3.16M | Sell |
|
|||||
|
2023
Q1 | $2.11M | Buy |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $2.67M | Sell |
|
|||||
|
2022
Q2 | $4.59M | Sell |
|
|||||
|
2022
Q1 | $10.1M | Sell |
|
|||||
|
2021
Q4 | $15.8M | Buy |
|
|||||
|
2021
Q3 | $5.34M | Buy |
|
|||||
|
2021
Q2 | $5.74M | Buy |
|